| Daniel Fimbres, RN | |
|
950 E Van Buren St, Avondale, AZ 85323-1506 | |
| (623) 344-6800 | |
| (623) 344-6801 |
| Full Name | Daniel Fimbres |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 950 E Van Buren St, Avondale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689191397 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP11221 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Urgent Care Services Llc | 4284921610 | 198 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
| Entity Name | Tri-city Express Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962580118 PECOS PAC ID: 2264436377 Enrollment ID: O20060901000335 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
| Entity Name | Banner Urgent Care Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316349855 PECOS PAC ID: 3678749496 Enrollment ID: O20111228000784 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
| Entity Name | Banner Urgent Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609229764 PECOS PAC ID: 4284921610 Enrollment ID: O20160928001188 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Fimbres, RN 950 E Van Buren St, Avondale, AZ 85323-1506 Ph: (623) 344-6800 | Daniel Fimbres, RN 950 E Van Buren St, Avondale, AZ 85323-1506 Ph: (623) 344-6800 |
News Archive
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.
A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
Certain prenatal risk factors are associated with the development of chronic kidney disease in children, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future studies should investigate whether modifying these factors could help protect children's kidney health.
› Verified 7 days ago
Mr. Justin Markel Belford, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3426 N 126th Dr, Avondale, AZ 85392 Phone: 623-695-4011 | |
Courtney Standifird, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10450 W Mcdowell Rd Ste 101, Avondale, AZ 85392 Phone: 623-935-1000 | |
Kia Lambeth, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 305, Avondale, AZ 85392 Phone: 623-936-3312 Fax: 623-936-4248 | |
Amy Christine Amore, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13075 W Mcdowell Rd Ste D106, Avondale, AZ 85392 Phone: 623-547-0522 | |
Mrs. Marytza Olivas-osuna, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13055 W Mcdowell Rd Ste G112, Avondale, AZ 85392 Phone: 623-322-5900 | |
Joyce Bour, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12729 W Monte Vista Rd, Avondale, AZ 85392 Phone: 623-792-0209 | |
Bolatito Oyeronke Okougbo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10926 W Ivory Ln, Avondale, AZ 85392 Phone: 623-977-7644 |